Year 2003 Paper two: Questions supplied by Tricia

Similar documents
GENETIC TESTING FOR NEUROFIBROMATOSIS

Corporate Medical Policy

Neurocutaneous Syndromes. Phakomatoses

Imaging in neurofibromatosis type 1: An original research article with focus on spinal lesions

The neurofibromatoses: more than just a medical curiosity

List the conditions known as neurophakomatosis and demonstrate their clinical findings:

Cranial Computed Tomographic Findings of Neurofibromatosis Type 2

Dr. T. Venkat Kishan Asst. Prof Department of Radiodiagnosis

Neurofibromatosis type 1 and RASopathies

ISPUB.COM. Neurofibromatosis-II. N Bahri, S Nathani, K Rathod, S Mody INTRODUCTION CASE REPORT

CLINICAL INFORMATION SHEET NEUROFIBROMATOSIS (NF)

Brainstem diffuse gliomas: radiologic findings.

Multiple tumours of peripheral nerves are often

Tumors of the Nervous System

Von Recklinghausen s Disease with a Giant Lipoma

Plexiform Tumor of the Orbit

Pediatric CNS Tumors. Disclosures. Acknowledgements. Introduction. Introduction. Posterior Fossa Tumors. Whitney Finke, MD

General: Brain tumors are lesions that have mass effect distorting the normal tissue and often result in increased intracranial pressure.

TABLES. Imaging Modalities Evidence Tables Table 1 Computed Tomography (CT) Imaging. Conclusions. Author (Year) Classification Process/Evid ence Class

Stereotactic Radiosurgery/Fractionated Stereotactic Radiotherapy for Acoustic Neuroma (Vestibular Schwannomas)

Spinal and para-spinal plexiform neurofibromas in NF1 patients, a clinical-radiological correlation study

Neurocutaneous Disorders NEUROFIBROMATOSIS 11/1/2012 NEUROFIBROMATOSIS TYPE1 GENETICS. NEUOFIBROMATOSIS type 1 Cutaneous Manifestations

Otolaryngologist s Perspective of Stereotactic Radiosurgery

Posterior fossa tumors: clues to differential diagnosis with case-based review

NON MALIGNANT BRAIN TUMOURS Facilitator. Ros Taylor Advanced Neurosurgical Nurse Practitioner Southmead Hospital Bristol

Advances In Orbital Neuropathology

RADIOLOGY TEACHING CONFERENCE

Rebecca J. Clark-Bash, R. EEG\EP T., CNIMeKnowledgePlus.net Page 1

Neurofibromatosis Type One: A Guide for Educators by Bruce R. Korf, M.D., Ph.D.

Tumors of the Central Nervous System

The Neurofibromatoses. Part 2: NF2 and Schwannomatosis

CLINICAL PEARLS IN OCULAR ONCOLOGY

Neurofibromatosis Type 2

Peter Canoll MD. PhD.

Rare variant of misme syndrome a case report with review of literature

THE CHILD WITH NEUROFIBROMATOSIS TYPE 1 (NF1) A GUIDE FOR

BRITISH BIOMEDICAL BULLETIN

CASE OF THE WEEK PROFESSOR YASSER METWALLY

Case Report Intracranial Capillary Hemangioma in the Posterior Fossa of an Adult Male

Brain tumors: tumor types

A Clinical Study of Type 2 Neurofibromatosis

Radiologic Evaluation of Petrous Apex Masses. Pavan Kavali, MS-IV Morehouse School of Medicine November 16, 2009

University of Washington Radiology Review Course: Strange and Specific Diagnoses. Case #1

Title. Author(s) Takahashi, Haruo. Issue Date Right.

Autosomal Dominant Polycystic Kidney Disease

NEURORADIOLOGY-NEUROPATHOLOGY CONFERENCE

TUMORS of nervous system

section 2 What Is Neurofibromatosis Type 1?

DEVELOPMENT OF BRAIN

CT & MRI Evaluation of Brain Tumour & Tumour like Conditions

PHAKOMATOSES SYNDROMES Michelle Willis, COMT, OSA

BRAIN STEM AND CEREBELLUM..

Brainstem and Cerebellum

DIRECT SURGERY FOR INTRA-AXIAL

Imaging of Hearing Loss

Imaging the Spinal Cord & Intradural Disease

Oligodendroglioma: imaging findings, radio-pathological correlation and evolution

Pediatric Retroperitoneal Masses Radiologic-Pathologic Correlation

MRI and CT of the CNS

Neurofibromatosis. Information Leaflet

FABRY DISEASE 12/30/2012. Ataxia-Telangiectasia. Ophthalmologic Signs of Genetic Neurological Disease

SEVERE PULMONARY ARTERY HYPERTENSION IN A PATIENT OF NEUROFIBROMATOSIS-1: A RARE ASSOCIATION

BILATERAL OPTIC MALIGNANT ASTROCYTOMA IN A 3 YEAR OLD CHILD WITH NFI CASE PRESENTATION

Neurofibromatosis 2: Genetics and Prenatal Diagnosis

Case Report Malignant Peripheral Nerve Sheath Tumor of the Inguinum and Angiosarcoma of the Scalp in a Child with Neurofibromatosis Type 1

Case Report A Very Rare Assocıatıon; Coexıstence of Breast Cancer, Pheochromocytoma and Neurofıbromatosıs Type 1 in a Female Patıent

Hemorrhagic vestibular schwannoma: an unusual clinical entity Case report

Neurofibromatosis type 1 and malignancy in childhood

Focal amyotrophy in neurofibromatosis 2

Cranial Nerve VII & VIII

INFORMATION FOR PATIENTS AND PROFESSIONALS

Cranial Nerve VIII (The Vestibulo-Cochlear Nerve)

Superficial Neurofibroma: A Lesion with Unique MRI Characteristics in Patients with Neurofibromatosis Type 1

Attenuation value in HU From -500 To HU From -10 To HU From 60 To 90 HU. From 200 HU and above

Computed Tomographic Evaluation of Posterior Fossa Lesions

Case Studies in CPA/IAC

A Journey Down The Canal

Case Report Multiple Intracranial Meningiomas: A Review of the Literature and a Case Report

Brainstem. Amadi O. Ihunwo, PhD School of Anatomical Sciences

Capt. Nazim ATA Aerospace Medicine Specialist Turkish Air Force AAMIMO 2013

DOWNLOAD OR READ : REVERSING NEUROFIBROMATOSIS TYPE 1 PDF EBOOK EPUB MOBI

Selected radiosurgery cases from the Rotating Gamma Institute Debrecen, Hungary

Genetics and Inborn Errors of Metabolism

NF1 AND ME.. A GUIDE TO THE BASICS

List the tumours that may arise in CPA:

CNS TUMORS. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria)

Role of 3D T2 weighted imaging at 3T in evaluation of cranial nerve pathologies - An overview

Laryngeal schwannoma - A rarely occurring benign tumor.

Laith Sorour. Facial nerve (vii):

Structural and functional imaging for the characterization of CNS lymphomas

The central nervous system

Acoustic Neuroma (vestibular schwannoma)

External carotid blood supply to acoustic neurinomas

Prognostic factors in pediatric brain-stem gliomas

Meningioma tumor. Meningiomas are named according to their location (Fig. 1) and cause various symptoms: > 1

JMSCR Vol 04 Issue 04 Page April 2016

The Natural History of Cerebellar Hemangioblastomas in von Hippel-Lindau Disease

Dosimetry, see MAGIC; Polymer gel dosimetry. Fiducial tracking, see CyberKnife radiosurgery

The CNS and PNS: How is our Nervous System Organized?

CNS pathology Third year medical students. Dr Heyam Awad 2018 Lecture 12: CNS tumours 2/3

Transcription:

question 43 A 42-year-old man presents with a two-year history of increasing right facial numbness. He has a history of intermittent unsteadiness, mild hearing loss and vertigo but has otherwise been well. Cranial magnetic resonance imagine (MRI) (T1 weighted following gadolinium contrast) is shown below. The most likely diagnosis is: A. multiple sclerosis B. neurofibromatosis type 2 C. cerebellar haemangioblastoma D. meningioma E. pontine glioma A. multiple sclerosis

B. neurofibromatosis type 2 Neurofibromatosis, a common neurocutaneous disorder, includes numerous different forms. Neurofibromatosis type 1, also known as von Recklinghausen's NF or NF1 is the most common type, and accounts for at least 85 percent of patients. Diagnostic criteria The hallmarks of NF1 are the multiple café-au-lait spots (CALS) and associated cutaneous neurofibromas. The diagnostic criteria developed by the NIH Consensus Conference in 1987 and updated in 1997 are based upon specific clinical features of NF1 (show table 1) [16-18]. According to these criteria, at least two of the following clinical features must be present to make the diagnosis of NF1: Six or more café-au-lait macules of greatest diameter >5 mm in prepubertal and >15 mm in postpubertal individuals Two or more neurofibromas of any type or one plexiform neurofibroma Freckling in the axillary or inguinal regions Optic glioma Two or more Lisch nodules (iris hamartomas) A distinctive bony lesion such as sphenoid dysplasia or thinning of the long bone cortex with or without pseudoarthrosis A first-degree relative (parent, sibling, or offspring) with NF1 based upon the above criteria Neurofibromatosis type 2 (NF2) is less frequent than NF1 and has a birth incidence of 1 in 30 000-40 000. It is caused by a dominant mutation in the NF2 gene which is located on chromosome 22. The NF2 gene codes for the protein Merlin/Schwannomin. The hallmarks of NF2 are the bilateral vestibular schwannomas (formerly called acoustic neuromas ). There are also clinical diagnostic criteria available to make the diagnosis: 1. Bilateral vestibular schwannomas (histology or MRI) 2. A parent, sibling or child with NF2 and either Unilateral vestibular schwannoma

Any two of the following: meningioma, glioma, schwannoma, posterior subcapsular lenticular opacities, cerebral calcification 3. Unilateral vestibular schwannoma and two or more of the following: meningioma, glioma, schwannoma, posterior subcapsular lenticular opacities, cerebral calcification 4. Multiple meningiomas (two or more) and one or more of the following: glioma, schwannoma, posterior subcapsular lenticular opacities, cerebral calcification Patients with NF2 sometimes have a few café-au-lait spots but not more than 5. They can have tumors of the peripheral nerves (schwannomas). These schwannomas are sometimes mistaken for neurofibromas. Symptoms of bilateral vestibular schwannomas usually begin in early adult life with decreased hearing, tinnitus or vertigo. Symptomatic spinal tumors are frequently observed. The actuarial survival after diagnosis is on average 15 years. NF type 2 Spinal tumors are found in up to 90 percent of patients with NF-2. The tumors are often multiple, consisting primarily of schwannomas, but including some meningiomas [7]. About 2 percent of all spinal schwannomas are seen in patients with NF-2, while the rest are sporadic [8]. (See "Risk factors for brain tumors" section on Genetic factors). DIAGNOSIS Contrast-enhanced magnetic resonance imaging (MRI) is the most sensitive and specific imaging modality to evaluate possible spinal column lesions. The majority of NSTs enhance diffusely with contrast, but heterogeneous enhancement can be seen when intratumoral cysts, hemorrhage or necrosis are present Cerbellar haemangioblastoma

Gadolinium-enhanced T1-weighted axial magnetic resonance image reveals a large right-sided cerebellar tumor. Meningionma Signs in CT or MRI images will vary according to the cellular expression of the tumour. It is usually well circumscribed, but can become locally invasive or may rarely undergo metaplasia. Typically on CT, the tumour is extra-axial, of greater density than adjacent normal brain, may contain calcification and enhances densely, after intravenous contrast. Cystic change has been recorded, but is rare ( 1-2 percent ). MRI scans of meningioma almost invariably show enhancement with IV Gadolinium contrast. E. pontine glioma Gliomas arising in the brainstem (midbrain, pons, and medulla oblongata) account for 10 to 20 percent of all central nervous system (CNS) tumors in children. They are more common in children than adults [1-4]. In the United States, for example, there are approximately 300 pediatric cases and 100 adult cases reported each year. In children, the median age at diagnosis is five to nine years of age, and the incidence is approximately equal between males and females.

On CT, these tumors infiltrate and enlarge the brain stem and secondarily displace the fourth ventricle. They commonly are hypodense but occasionally are of increased density compared to normal brain as seen on Film.3 in a different child. Calcification and cyst formation are infrequent (12%), and approximately half demonstrate enhancement after contrast (Film.4). When present, enhancement patterns are variable, with diffuse, nodular, or ring enhancement seen. A small number of these tumors may demonstrate exophytic growth into the posterior fossa cisterns, particularly the cerebellopontine angle cistern. These tumors tend to enhance with contrast administration. Because of Hounsfield artifact in the posterior fossa, a small percentage of brain stem gliomas will be overlooked on initial CT scans. The superior imaging capability of MRI for brain stem and posterior fossa pathology allows recognition and characterization of lesions that are poorly delineated by CT, such as isodense or nonenhancing tumors.